| |
| Device | Abbott RealTime IDH1 |
| Generic Name | Somatic gene mutation detection system |
| Applicant | Abbott Molecular, Inc. 1300 E Touhy Ave. Des Plaines, IL 60018 |
| PMA Number | P170041 |
| Supplement Number | S007 |
| Date Received | 06/27/2023 |
| Decision Date | 10/24/2023 |
| Product Code |
OWD |
| Advisory Committee |
Molecular Genetics |
| Clinical Trials | NCT02074839
|
| Supplement Type | Normal 180 Day Track |
| Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for expanding the indication for use of Abbott RealTime IDH1 as an aid in identifying myelodysplastic syndrome (MDS) patients with isocitrate dehydrogenase-1 (IDH1) mutation for treatment with TIBSOVO® (ivosidenib). |